Great Lakes Advisors’s Bio-Techne TECH Stock Holding History

Great Lakes Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,644	Closed	-$213K	–	757
2021 Q4	$213K	Buy	+1,644	New	+$202K	﹤0.01%	663

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Great Lakes Advisors's TECH Position: Q1 2022 in Review

Great Lakes Advisors sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 1,644 shares — an estimated $213K sold.

Great Lakes Advisors first reported a position in TECH in Q4 2021 and held it in 1 quarter. The position peaked at $213K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

Great Lakes Advisors reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
Great Lakes Advisors sold 1,644 Bio-Techne shares in Q1 2022, an estimated $213K.
Great Lakes Advisors first reported a position in Bio-Techne in Q4 2021 and held it in 1 quarter.
Great Lakes Advisors's Bio-Techne position peaked at $213K in Q4 2021.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Great Lakes Advisors's 13F filing for Q1 2022, filed 6 May 2022.